Olav Steinnes
Directeur Financier/CFO chez Inven2 AS
Profil
Olav Steinnes is currently the Director at Ostomycure AS, ProfMOF AS, CardiNor AS, Prosa Security AS, and Orphan Diagnostics AS.
He is also the Chief Financial Officer at Inven2 AS since 2011.
Previously, he held positions as Chairman at Qotics AS and Serca Pharmaceuticals AS.
He was also the Managing Director at Axis-Shield Ltd.
and Director at Mole Genetics AS, NeoRad AS, Cgene AS, Medinnova AS, Serodus ASA, Nordic Nanovector ASA, Zelluna Immunotherapy AS, and Vice President-Diagnostics at Takeda AS.
Mr. Steinnes graduated from the Norwegian School of Economics & Business Administration.
Postes actifs de Olav Steinnes
| Sociétés | Poste | Début |
|---|---|---|
Inven2 AS
 Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | Directeur Financier/CFO | 01/01/2011 |
Ostomycure AS
 Ostomycure AS Miscellaneous Commercial ServicesCommercial Services Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway. | Directeur/Membre du Conseil | - |
ProfMOF AS
 ProfMOF AS Miscellaneous Commercial ServicesCommercial Services ProfMOF AS manufactures metal organic frameworks. The company was founded by Sachin Maruti Chavan, Unni Olsbye, Karl Petter Lillerud and Norbert Stock in 2015 and is headquartered in Kongsberg, Norway. | Directeur/Membre du Conseil | - |
CardiNor AS
 CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway. | Directeur/Membre du Conseil | - |
Prosa Security AS
 Prosa Security AS Packaged SoftwareTechnology Services Prosa Security AS develops cyber security software. Its products r include risk analysis report, system overview, Security in vendor applications, mobile application Security tool and software development Security and It offers feasibility study, training and consulting services. The company was founded in 2015 and is headquartered in Oslo, Norway. | Directeur/Membre du Conseil | - |
Orphan Diagnostics AS
 Orphan Diagnostics AS Medical SpecialtiesHealth Technology Orphan Diagnostics AS engaged in the provision of focusing on point-of-care diagnostics in clinical toxicology. The company was founded in 2016 and is headquartered in Oslo, Norway. | Directeur/Membre du Conseil | - |
Anciens postes connus de Olav Steinnes
| Sociétés | Poste | Fin |
|---|---|---|
Mole Genetics AS
 Mole Genetics AS BiotechnologyHealth Technology Mole Genetics AS manufactures and sells instruments & pre-filled reagent cartridges for genetic research. The firm product GeneMole is used for automation of DNA and RNA extraction system and MoleStrips is used for prefilled disposable reagent strips. The company was founded by Ole Jesper Dahlberg, Frank Larsen, Arne Deggerdal, and Tone Yrvum in June 2005 and is headquartered in Lysaker, Norway. | Directeur/Membre du Conseil | 31/05/2012 |
Medinnova AS
 Medinnova AS Investment ManagersFinance Medinnova AS (Medinnova) is the investment development subsidiary of Inven2 AS in Norway. The firm was established in 2003 to provide investment management services to hospitals and other health organizations, in addition to research communities in the Southern and Eastern regions of Norway. Located in Oslo, Medinnova provides consulting services and financing for projects that range from business development, research collaboration, innovation and industrial development, as well as administration of research funds for the national health service. The firm also serves as the Technology Transfer Office for university hospitals in the Oslo region, such as Rikshospitalet - Radiumhospitalet HF, Ullevål University Hospital HF, Aker University Hospital HF and Akershus University Hospital HF. | President | 01/01/2011 |
| AXIS-SHIELD LTD | Directeur Général | 31/12/2007 |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Olav Steinnes
| Norwegian School of Economics & Business Administration | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Medinnova AS
Medinnova AS Investment ManagersFinance Medinnova AS (Medinnova) is the investment development subsidiary of Inven2 AS in Norway. The firm was established in 2003 to provide investment management services to hospitals and other health organizations, in addition to research communities in the Southern and Eastern regions of Norway. Located in Oslo, Medinnova provides consulting services and financing for projects that range from business development, research collaboration, innovation and industrial development, as well as administration of research funds for the national health service. The firm also serves as the Technology Transfer Office for university hospitals in the Oslo region, such as Rikshospitalet - Radiumhospitalet HF, Ullevål University Hospital HF, Aker University Hospital HF and Akershus University Hospital HF. | Finance |
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
Takeda AS
 Takeda AS Pharmaceuticals: MajorHealth Technology Takeda AS operates as a pharmaceutical company. It manufactures and distributes generic medicines. The firm offers therapeutics in the areas such as cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. The company founded by Morten Nyegaard in 1874 and is headquartered in Asker, Norway. | Health Technology |
Axis-Shield Ltd.
 Axis-Shield Ltd. Medical SpecialtiesHealth Technology Axis-Shield Ltd. operates as a biotechnology company. The company was founded 1993 and is headquartered in the United Kingdom. | Health Technology |
Serodus ASA
 Serodus ASA BiotechnologyHealth Technology Serodus ASA is a bio-medical company, which engages in the development of medicines for the treatment of diabetes related complications. It focuses on diabetic kidney disease, diabetic retinopathy, type 1 diabetes, and diabetic foot ulcers. The company was founded by Finn Olav Levy on January 21, 2008 and is headquartered in Oslo, Norway. | Health Technology |
NeoRad AS
 NeoRad AS Medical SpecialtiesHealth Technology NeoRad AS creates products for medical procedures. It specializes in radiology, image guided, needle holder, functional ultrasound, Navigation and interventional oncology. The company was founded by Knut Brabrand on August 28, 1998 and is headquartered in Oslo, Norway. | Health Technology |
Inven2 AS
Inven2 AS Investment ManagersFinance Inven2 AS (Inven2) is the venture capital subsidiary of the University of Oslo and Oslo University Hospital, Norway's largest pioneering research university and hospital. The firm was created in 2010 when technology transfer company Birkeland Innovasjon AS and investment development firm Medinnova merged. Located in Oslo, Inven2 manages the Inven2 Fund, commercializing innovations, administering the fund and conducting and following up clinical trials. | Finance |
Mole Genetics AS
Mole Genetics AS BiotechnologyHealth Technology Mole Genetics AS manufactures and sells instruments & pre-filled reagent cartridges for genetic research. The firm product GeneMole is used for automation of DNA and RNA extraction system and MoleStrips is used for prefilled disposable reagent strips. The company was founded by Ole Jesper Dahlberg, Frank Larsen, Arne Deggerdal, and Tone Yrvum in June 2005 and is headquartered in Lysaker, Norway. | Health Technology |
Cgene AS
 Cgene AS Miscellaneous Commercial ServicesCommercial Services Cgene AS is a holding company that offers contract-based research within the field of in vivo molecular imaging. It is a biotechnology company that has available mice models designed to report real-time gene activity in a living animal, reflecting normal or pathological molecular processes in conditions such as inflammation, infection, oxidative stress, cancer, and cardiovascular disease, hypoxia, and retinoid effects. It develops and makes commercially available new reporter models for in vivo molecular imaging purposes. It also tailors transgenic models to meet specific customer needs. Its reporter models serve as preclinical tool for cost-efficient drug screening by pharmaceutical companies. The company was founded by Harald Carlsen and Rune Blomhoff on April 22, 1985 and is headquartered in Oslo, Norway. | Commercial Services |
Qotics AS
 Qotics AS Pharmaceuticals: MajorHealth Technology Qotics AS operates as a biotechnology company. It develops drugs against multi-resistant Gram-negative bacteria. It provides treatment for Escherichia coli with viral vectors. The company was founded on March 30, 2007 and is headquartered in Oslo, Norway. | Health Technology |
Ostomycure AS
Ostomycure AS Miscellaneous Commercial ServicesCommercial Services Ostomycure AS develops solution for evacuating of fluids from the intestines. It include product called TIES is used for patients that have their colon or urinary bladder removed and thus need to get rid of the waste from the ileum in another fashion than the normal way. The company was founded by Bente Buveruds in 2003 and is headquartered in Oslo, Norway. | Commercial Services |
ProfMOF AS
ProfMOF AS Miscellaneous Commercial ServicesCommercial Services ProfMOF AS manufactures metal organic frameworks. The company was founded by Sachin Maruti Chavan, Unni Olsbye, Karl Petter Lillerud and Norbert Stock in 2015 and is headquartered in Kongsberg, Norway. | Commercial Services |
CardiNor AS
CardiNor AS BiotechnologyHealth Technology CardiNor AS develops, produces, and sells in-vitro diagnostic products. It establishes a blood test for elevated levels of Secretoneurin that may indicate that a patient has a heart disease. The company was founded on June 25, 2015 and is headquartered in Oslo, Norway. | Health Technology |
Prosa Security AS
Prosa Security AS Packaged SoftwareTechnology Services Prosa Security AS develops cyber security software. Its products r include risk analysis report, system overview, Security in vendor applications, mobile application Security tool and software development Security and It offers feasibility study, training and consulting services. The company was founded in 2015 and is headquartered in Oslo, Norway. | Technology Services |
Zelluna Immunotherapy AS
 Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway. | Health Technology |
Orphan Diagnostics AS
Orphan Diagnostics AS Medical SpecialtiesHealth Technology Orphan Diagnostics AS engaged in the provision of focusing on point-of-care diagnostics in clinical toxicology. The company was founded in 2016 and is headquartered in Oslo, Norway. | Health Technology |
Serca Pharmaceuticals AS
 Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway. | Health Technology |
